Contact Molecules for Homologous Proteins | ||||
[Full Bars] |
[SiteTable] |
|
[Back to Search Page] |
[Back to HOMCOS] |
[SupCon3D] |
[help] |
seq_id(%): [0] [30] [40] [50] [60] [70] [80] [90] [95] [100] | [show] [download] [help] |
PID | QueryLength | Homolgous Sequence in PDB | UniProt Query | TITLE |
15155 | 1273 | 59 | P0DTC2(SPIKE_SARS2) | RecName: Full=Spike glycoprotein ; Short=S glycoprotein ;AltName: Full=E2 ;AltName: Full=Peplomer protein ;Contains: RecName: Full=Spike protein S1 ;Contains: RecName: Full=Spike protein S2 ;Contains: RecName: Full=Spike protein S2' ;Flags: Precursor; |
QUERYSEQ |
MFVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYFASTEKSNIIRGWIFGTTLDSKTQSLLIVNNATNVVIKVCEFQFCNDPFLGVYYHKNNK SWMESEFRVYSSANNCTFEYVSQPFLMDLEGKQGNFKNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGFSALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETK CTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDDFTGCVIAWNSNNLDSKVGGNYN YLYRLFRKSNLKPFERDISTEIYQAGSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFNFNGLTGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITP GTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECS NLLLQYGSFCTQLNRALTGIAVEQDKNTQEVFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDCLGDIAARDLICAQKFNGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAM QMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNQNAQALNTLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRASANLAATKMSECVLGQSKRVDFCGKGYHLM SFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDL QELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDDSEPVLKGVKLHYT |
1273 | region | name | description |
1-13 | SIGNAL | ||
14-1273 | CHAIN | /note="Spike glycoprotein" /id="PRO_0000449646" | |
14-685 | CHAIN | /note="Spike protein S1" /id="PRO_0000449647" | |
686-1273 | CHAIN | /note="Spike protein S2" /id="PRO_0000449648" | |
816-1273 | CHAIN | /note="Spike protein S2'" /id="PRO_0000449649" | |
14-1213 | TOPO_DOM | /note="Extracellular" | |
1214-1234 | TRANSMEM | /note="Helical" | |
1235-1273 | TOPO_DOM | /note="Cytoplasmic" | |
14-303 | DOMAIN | /note="BetaCoV S1-NTD" | |
334-527 | DOMAIN | /note="BetaCoV S1-CTD" ECO:0000269|PubMed:32132184" | |
1-26 | REGION | /note="Disordered" | |
67-80 | REGION | /note="Disordered" | |
142-164 | REGION | /note="Disordered" | |
173-185 | REGION | /note="Disordered" | |
246-262 | REGION | /note="Disordered" | |
280-301 | REGION | /note="Putative superantigen; may bind T-cell receptor alpha/TRAC" | |
319-541 | REGION | /note="Receptor-binding domain (RBD)" | |
319-335 | REGION | /note="Disordered" | |
403-405 | REGION | /note="Integrin-binding motif;" | |
437-508 | REGION | /note="Receptor-binding motif; binding to human ACE2" | |
448-456 | REGION | /note="Immunodominant HLA epitope recognized by the CD8+; called NF9 peptide" | |
455-490 | REGION | /note="Disordered" | |
519-541 | REGION | /note="Disordered" | |
621-640 | REGION | /note="Disordered" | |
673-687 | REGION | /note="Disordered" | |
681-684 | REGION | /note="Putative superantigen; may bind T-cell receptor beta/TRBC1" | |
816-837 | REGION | /note="Fusion peptide 1" | |
828-853 | REGION | /note="Disordered" | |
835-855 | REGION | /note="Fusion peptide 2" | |
920-970 | REGION | /note="Heptad repeat 1" | |
1163-1202 | REGION | /note="Heptad repeat 2" | |
949-993 | COILED | ||
1176-1203 | COILED | ||
1235-1235 | LIPID | /note="S-palmitoyl cysteine; by host ZDHHC20" | |
1236-1236 | LIPID | /note="S-palmitoyl cysteine; by host ZDHHC20" | |
1240-1240 | LIPID | /note="S-palmitoyl cysteine; by host ZDHHC20" | |
1241-1241 | LIPID | /note="S-palmitoyl cysteine; by host ZDHHC20" | |
1243-1243 | LIPID | /note="S-palmitoyl cysteine; by host ZDHHC20" | |
1247-1247 | LIPID | /note="S-palmitoyl cysteine; by host ZDHHC20; partial" | |
1248-1248 | LIPID | /note="S-palmitoyl cysteine; by host ZDHHC20; partial" | |
1250-1250 | LIPID | /note="S-palmitoyl cysteine; by host ZDHHC20; partial" | |
1253-1253 | LIPID | /note="S-palmitoyl cysteine; by host ZDHHC20; partial" | |
1254-1254 | LIPID | /note="S-palmitoyl cysteine; by host ZDHHC20; partial" | |
1-1273 | DISORDER | predicted by DISOPRED |
MONOMER | |||||||
1273 | |||||||
pdb_id | a1 | identity[%]2 | description | ||||
7fg7 | A | 100.0 | SPIKE_SARS2 Spike glycoprotein | ||||
6xr8 | A | 100.0 | SPIKE_SARS2 Spike glycoprotein | ||||
1.a1:asym_id for the homologue. 2.identity[%]2:sequence identity between the query and the homologue. |
HETERO | |||||||
1273 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
7cwl[12] | E | Fab P17 heavy chain[120 aa] | A | 100.0 /100.0 |
11 /11 |
SPIKE_SARS2 Spike glycoprotein | |
7cwl[12] | G | Fab P17 light chain[108 aa] | A | 100.0 /100.0 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein | |
7cwl[2] | G | Fab P17 light chain[108 aa] | B | 100.0 /100.0 |
6 /6 |
SPIKE_SARS2 Spike glycoprotein | |
7cwn[3] | N | light chain of H014 Fab[107 aa] | A | 100.0 /100.0 |
8 /8 |
SPIKE_SARS2 Spike glycoprotein | |
7cws[3] | G | Light Chain of H014 Fab[107 aa] | M | 100.0 /100.0 |
8 /8 |
SPIKE_SARS2 Spike glycoprotein | |
7cwn[3] | O | heavy chain of H014 Fab[122 aa] | A | 100.0 /100.0 |
16 /16 |
SPIKE_SARS2 Spike glycoprotein | |
7cws[3] | H | Heavy Chain of H014 Fab[122 aa] | M | 100.0 /100.0 |
8 /8 |
SPIKE_SARS2 Spike glycoprotein | |
7cws[6] | I | Heavy Chain of FC05 Fab[120 aa] | M | 100.0 /100.0 |
10 /10 |
SPIKE_SARS2 Spike glycoprotein | |
7cwu[3] | C | heavy chain of FC05 Fab[120 aa] | G | 100.0 /100.0 |
10 /10 |
SPIKE_SARS2 Spike glycoprotein | |
7cws[6] | J | Light Chain of FC05 Fab[109 aa] | M | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein | |
7cwu[3] | D | light chain of FC05 Fab[109 aa] | G | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein | |
7cwt[3] | D | Light chain Fab of HB27[111 aa] | A | 100.0 /100.0 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein | |
7cwt[1] | J | Light chain Fab of HB27[111 aa] | B | 100.0 /100.0 |
7 /7 |
SPIKE_SARS2 Spike glycoprotein | |
7cwt[3] | E | Heavy chain Fab of HB27[118 aa] | A | 100.0 /100.0 |
12 /12 |
SPIKE_SARS2 Spike glycoprotein | |
7fg2[2] | B | K-874A VHH[116 aa] | A | 100.0 /100.0 |
12 /12 |
SPIKE_SARS2 Spike glycoprotein | |
7xy4[2] | D | VHH21[121 aa] | A | 100.0 /100.0 |
12 /12 |
SPIKE_SARS2 Spike glycoprotein | |
7xy4[1] | D | VHH21[121 aa] | B | 100.0 /100.0 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein | |
7xy4[1] | D | VHH21[121 aa] | C | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
COMPOUND | |||||||
1273 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
6xr8[54] | NA |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein | |
6xr8[27] | OA |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
5 /5 |
SPIKE_SARS2 Spike glycoprotein | |
6xr8[21] | QA |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein | |
6xr8[24] | RA |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein | |
6xr8[9] | SA |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein | |
6xr8[2] | TA |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein | |
6zb4[9] | F |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein | |
6zb4[34] | G |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein | |
6zb4[9] | H |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein | |
6zb4[24] | I |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein | |
6zb4[12] | J |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein | |
6zb4[10] | P |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein | |
6zb4[9] | W |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein | |
6zb4[5] | F |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
B | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein | |
6zb4[7] | L |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
B | 100.0 /100.0 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein | |
6zb4[11] | S |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
B | 100.0 /100.0 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein | |
6zb4[20] | U |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
B | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein | |
6zb5[1] | K |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
C | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein | |
6zp0[3] | AA |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein | |
6zp0[9] | KA |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein | |
6zp0[3] | P |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein | |
6zp0[3] | PA |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein | |
6zp0[3] | Q |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
5 /5 |
SPIKE_SARS2 Spike glycoprotein | |
6zp0[2] | QA |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein | |
6zp0[3] | R |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein | |
6zp0[3] | S |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein | |
6zp0[3] | T |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein | |
6zp0[15] | U |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein | |
6zp0[3] | V |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein | |
6zp0[3] | W |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein | |
6zp0[3] | X |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein | |
6zp0[13] | Y |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein | |
6zp0[11] | Z |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein | |
7cwl[13] | FA |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein | |
7cwl[9] | R |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein | |
7cws[5] | EA |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
M | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein | |
7cwt[6] | R |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein | |
7cwt[8] | S |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
7 /7 |
SPIKE_SARS2 Spike glycoprotein | |
7cwt[5] | T |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein | |
7cwt[2] | Z |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
B | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein | |
7e7b[15] | RA |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
2 /2 |
SPIKE_SARS2 CO1A1_HUMAN Spike glycoprotein,Collagen alpha-1(I) chain | |
7od3[3] | L |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein | |
7od3[3] | N |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein | |
7qur[6] | Q |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
4 /4 |
SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin | |
7qur[6] | Y |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
4 /4 |
SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin | |
7wgv[3] | BA |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein | |
7wgv[3] | DA |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
5 /5 |
SPIKE_SARS2 Spike glycoprotein | |
7wgv[6] | GA |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein | |
7wgv[6] | HA |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein | |
7wgv[3] | IA |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein | |
7wgv[8] | S |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein | |
7wgv[8] | U |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein | |
7wgv[8] | V |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein | |
7wgv[5] | W |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein | |
7wgv[7] | X |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein | |
7wgv[10] | Y |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein | |
7xy4[2] | G |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein | |
7xy4[3] | R |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein | |
7xy4[1] | GA |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
B | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein | |
7xy4[1] | HA |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
B | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein | |
7xy4[1] | FA |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
C | 100.0 /100.0 |
5 /5 |
SPIKE_SARS2 Spike glycoprotein | |
7e7b[3] | XA |
VCG
2-hydroxyethyl 2-deoxy-3,5-bis-O-(2-hydroxyethyl)-.. |
A | 100.0 /100.0 |
11 /11 |
SPIKE_SARS2 CO1A1_HUMAN Spike glycoprotein,Collagen alpha-1(I) chain | |
7e7b[3] | YA |
VCG
2-hydroxyethyl 2-deoxy-3,5-bis-O-(2-hydroxyethyl)-.. |
A | 100.0 /100.0 |
3 /3 |
SPIKE_SARS2 CO1A1_HUMAN Spike glycoprotein,Collagen alpha-1(I) chain | |
7qur[3] | BA |
GE9
2,3,5-tris(iodanyl)benzamide[12 atoms] |
A | 100.0 /100.0 |
5 /5 |
SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin | |
7qur[3] | CA |
SIA
N-acetyl-alpha-neuraminic acid[21 atoms] |
A | 100.0 /100.0 |
8 /8 |
SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin | |
7wgv[5] | EA |
BLR
3-[5-[(Z)-(4-ethenyl-3-methyl-5-oxidanylidene-pyrr.. |
A | 100.0 /100.0 |
11 /11 |
SPIKE_SARS2 Spike glycoprotein | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
OTHERPOLY | |||||||
1273 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
6xr8[3] | D | alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. | A | 100.0 /100.0 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein | |
6xr8[3] | G | alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. | A | 100.0 /100.0 |
7 /7 |
SPIKE_SARS2 Spike glycoprotein | |
6xr8[3] | J | alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. | A | 100.0 /100.0 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein | |
6xr8[3] | JA | alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. | A | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein | |
6xr8[3] | K | alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. | A | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein | |
6xr8[3] | L | alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. | A | 100.0 /100.0 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein | |
6xr8[3] | M | alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. | A | 100.0 /100.0 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein | |
6xr8[3] | N | alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. | A | 100.0 /100.0 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein | |
6xr8[3] | V | alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. | A | 100.0 /100.0 |
6 /6 |
SPIKE_SARS2 Spike glycoprotein | |
6xr8[6] | E | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /100.0 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein | |
6xr8[3] | H | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /100.0 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein | |
6xr8[9] | I | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein | |
6xr8[9] | U | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /100.0 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein | |
6zb4[25] | D | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /100.0 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein | |
6zp0[6] | D | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /100.0 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein | |
6zp0[6] | E | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /100.0 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein | |
6zp0[6] | F | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /100.0 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein | |
6zp0[6] | G | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein | |
7cwm[20] | J | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /100.0 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein | |
7cwm[21] | L | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /100.0 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein | |
7cwm[15] | M | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /100.0 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein | |
7cwm[15] | N | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /100.0 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein | |
7cwm[13] | J | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | C | 100.0 /100.0 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein | |
7cws[9] | P | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | M | 100.0 /100.0 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein | |
7e7b[5] | D | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /100.0 |
4 /4 |
SPIKE_SARS2 CO1A1_HUMAN Spike glycoprotein,Collagen alpha-1(I) chain | |
7e7b[5] | DA | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 CO1A1_HUMAN Spike glycoprotein,Collagen alpha-1(I) chain | |
7e7b[6] | H | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /100.0 |
3 /3 |
SPIKE_SARS2 CO1A1_HUMAN Spike glycoprotein,Collagen alpha-1(I) chain | |
7e7b[6] | J | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /100.0 |
5 /5 |
SPIKE_SARS2 CO1A1_HUMAN Spike glycoprotein,Collagen alpha-1(I) chain | |
7e7b[3] | K | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /100.0 |
5 /5 |
SPIKE_SARS2 CO1A1_HUMAN Spike glycoprotein,Collagen alpha-1(I) chain | |
7e7b[6] | M | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /100.0 |
2 /2 |
SPIKE_SARS2 CO1A1_HUMAN Spike glycoprotein,Collagen alpha-1(I) chain | |
7e7b[6] | O | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /100.0 |
3 /3 |
SPIKE_SARS2 CO1A1_HUMAN Spike glycoprotein,Collagen alpha-1(I) chain | |
7wgv[8] | D | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /100.0 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein | |
7wgv[8] | E | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /100.0 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein | |
7wgv[4] | F | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein | |
7wgv[7] | H | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /100.0 |
5 /5 |
SPIKE_SARS2 Spike glycoprotein | |
7wgv[6] | Q | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /100.0 |
6 /6 |
SPIKE_SARS2 Spike glycoprotein | |
7wgx[3] | E | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /100.0 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein | |
6xr8[3] | F | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. | A | 100.0 /100.0 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein | |
6xr8[3] | O | alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-.. | A | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein | |
7qur[6] | G | alpha-L-fucopyranose-(1-3)-[2-acetamido-2-deoxy-be.. | A | 100.0 /100.0 |
2 /2 |
SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin | |
7qur[6] | K | alpha-L-fucopyranose-(1-3)-[2-acetamido-2-deoxy-be.. | A | 100.0 /100.0 |
3 /3 |
SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
HOMO | |||||||
1273 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
6xr8[36] | B | SPIKE_SARS2 Spike glycoprotein[1107 aa] | A | 100.0 /100.0 |
134 /134 |
SPIKE_SARS2 Spike glycoprotein | |
6xr8[36] | C | SPIKE_SARS2 Spike glycoprotein[1107 aa] | A | 100.0 /100.0 |
123 /123 |
SPIKE_SARS2 Spike glycoprotein | |
6zp0[19] | B | SPIKE_SARS2 Spike glycoprotein[1030 aa] | A | 100.0 /100.0 |
86 /86 |
SPIKE_SARS2 Spike glycoprotein | |
6zp0[19] | C | SPIKE_SARS2 Spike glycoprotein[1030 aa] | A | 100.0 /100.0 |
98 /98 |
SPIKE_SARS2 Spike glycoprotein | |
7wgy[1] | B | SPIKE_SARS2 Spike glycoprotein[821 aa] | A | 100.0 /100.0 |
73 /73 |
SPIKE_SARS2 Spike glycoprotein | |
7wgy[1] | B | SPIKE_SARS2 Spike glycoprotein[821 aa] | C | 100.0 /100.0 |
55 /55 |
SPIKE_SARS2 Spike glycoprotein | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
PRECIPITANT | |||||||
1273 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
6zb4[11] | FA |
EIC
LINOLEIC ACID[20 atoms] |
A | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein | |
6zb4[15] | K |
EIC
LINOLEIC ACID[20 atoms] |
A | 100.0 /100.0 |
10 /10 |
SPIKE_SARS2 Spike glycoprotein | |
7wgv[3] | AA |
EIC
LINOLEIC ACID[20 atoms] |
A | 100.0 /100.0 |
15 /15 |
SPIKE_SARS2 Spike glycoprotein | |
7wgv[3] | AB |
EIC
LINOLEIC ACID[20 atoms] |
A | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein | |
7e7b[6] | VA |
ELA
9-OCTADECENOIC ACID[20 atoms] |
A | 100.0 /100.0 |
14 /14 |
SPIKE_SARS2 CO1A1_HUMAN Spike glycoprotein,Collagen alpha-1(I) chain | |
7e7b[6] | WA |
ELA
9-OCTADECENOIC ACID[20 atoms] |
A | 100.0 /100.0 |
4 /4 |
SPIKE_SARS2 CO1A1_HUMAN Spike glycoprotein,Collagen alpha-1(I) chain | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. |